Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 20.07.2026 1 ACS Biomater Sci Eng 1 Acta Obstet Gynecol Scand 6 Am J Cancer Res 2 Am J Obstet Gynecol 1 Ann Diagn Pathol 1 bioRxiv 1 BMC Cancer 1 BMC Infect Dis 1 BMC Med Imaging 2 BMC Public Health 3 BMC Womens Health 1 Br J Health Psychol 1 Brachytherapy 1 Cancer Manag Res 1 Cancer Med 2 Cancers (Basel) 1 Cell Commun Signal 1 Cell Death Dis 2 Clin Oncol (R Coll Radiol) 1 Comput Biol Chem 1 Cytotechnology 1 Data Brief 1 Discov Nano 1 Discov Oncol 1 Ecancermedicalscience 2 Front Immunol 2 Front Oncol 3 Front Public Health 1 Funct Integr Genomics 1 Glob Epidemiol 1 Glob Ment Health (Camb) 2 Gynecol Oncol 1 Gynecol Oncol Rep 1 Health Sci Rep 1 Healthcare (Basel) 1 Histol Histopathol 2 Int J Gynaecol Obstet 2 Int J Gynecol Cancer 1 Int J Mol Med 1 Int J Mol Sci 1 Int J Radiat Oncol Biol Phys 1 Int J STD AIDS 2 Int J Womens Health 1 J Clin Med 1 J Comput Assist Tomogr 1 J Egypt Natl Canc Inst 1 J Family Med Prim Care 2 J Pharm Sci 2 J Prev Med Hyg 1 JAMA Netw Open 1 JCO Glob Oncol 1 Jpn J Radiol 1 Lasers Med Sci 1 Med Chem Res 1 Onco Targets Ther 1 Oncol Lett 1 Oncologist 1 Pathobiology 2 PLoS One 1 PLoS Pathog 1 Probiotics Antimicrob Proteins 2 Rep Pract Oncol Radiother 1 Reprod Fertil 1 Reprod Sci 1 Rev Esp Patol 2 RMD Open 2 Sci Rep 1 Tissue Cell 2 Transl Cancer Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

ACS Biomater Sci Eng

1. WAHID A, Maharaj R, Meiring M, Anand K, et al
   Extracellular Vesicles as Emerging Cervical Cancer Diagnostic and Molecular Signatures of Tumor and Immune Dynamics.
   ACS Biomater Sci Eng. 2026 Jul 14. doi: 10.1021/acsbiomaterials.6c00063.
   PubMed         Abstract available
   
   

   
   Acta Obstet Gynecol Scand

2. BERTELSEN VM, Booth BB, Tranberg M, Petersen LK, et al
   Assessing the clinical value of cervical biopsies in individuals with transformation zone type 3 at colposcopy: A cross-sectional study.
   Acta Obstet Gynecol Scand. 2026;105:1597-1606.
   PubMed         Abstract available
   
   

   
   Am J Cancer Res

3. WANG J, Lin F, Chen X
   Efficacy of immune checkpoint inhibitors plus chemotherapy versus chemotherapy-based control in cervical cancer: a meta-analysis.
   Am J Cancer Res. 2026;16:2131-2147.
   PubMed         Abstract available
   
   
4. SU L, Chen R, He T, Su X, et al
   USP5 promotes glycolysis in cervical cancer by stabilizing FOXM1.
   Am J Cancer Res. 2026;16:2329-2341.
   PubMed         Abstract available
   
   
5. ZHAO Y, Zhou H
   Serum USP1 and PD-L1 levels independently predict treatment response and prognosis in cervical cancer: a retrospective cohort study.
   Am J Cancer Res. 2026;16:2458-2480.
   PubMed         Abstract available
   
   
6. XU Y, Li S, Wang B, Huang J, et al
   Impact of laparoscopic versus open surgery on 5-year survival in patients with stage IA2-IB1 cervical cancer: a retrospective cohort study.
   Am J Cancer Res. 2026;16:2577-2611.
   PubMed         Abstract available
   
   
7. GUO Y, Zhang Y, Zhang S, Guo J, et al
   UBE2J2-mediated ubiquitination modification of MCM6 regulates proliferation and migration of cervical cancer cells.
   Am J Cancer Res. 2026;16:2355-2366.
   PubMed         Abstract available
   
   
8. ZHU B, Ge Y, Wen Y, Wu Y, et al
   DDOST mediates cervical cancer cell malignant progression by interacting with SMARCA4.
   Am J Cancer Res. 2026;16:2377-2388.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

9. LU TF, Shih YH, Chen YF, Fan CT, et al
   Association of Hormone Therapy with Long-Term Outcomes After Chemoradiation for Locally Advanced Cervical Cancer.
   Am J Obstet Gynecol. 2026 Jul 17:S0002-9378(26)00366.
   PubMed         Abstract available
   
   
10. HULMI J, Virtanen A, Sadeluoto H, Tarkkanen J, et al
    Histological outcomes and colposcopic findings in patients with persistent high-risk human papillomavirus infection without major cytological findings.
    Am J Obstet Gynecol. 2026;235:356-364.
    PubMed         Abstract available
    
    

    
    Ann Diagn Pathol

11. WANG Y, Yao Y, Shi H, Lu W, et al
    Analysis of SOX2 and SOX17 expression in cervical HPV-associated adenocarcinoma in situ: Correlation with histologic variants.
    Ann Diagn Pathol. 2026;84:152674.
    PubMed         Abstract available
    
    

    
    bioRxiv

12. IDEN M, Schmidt R, Mohammed RDAS, Dlugi TA, et al
    TAOK3 inhibition constrains invasion, potentiates paclitaxel, and reprograms the tumor microenvironment toward anti-tumor immunity in cervical cancer.
    bioRxiv [Preprint]. 2026 Jul 6:2026.07.04.736128.
    PubMed         Abstract available
    
    

    
    BMC Cancer

13. LEMRABETT S, Elhailouch FZ, Gourinda A, Mezzoug N, et al
    Awareness and acceptability of HPV vaccination among parents of young girls in northern Morocco: a mixed-methods study.
    BMC Cancer. 2026 May 23. doi: 10.1186/s12885-026-16111.
    PubMed         Abstract available
    
    

    
    BMC Infect Dis

14. HOSSEIN ZADEH S, Habibnia S, Rokni M
    Prevalence and genotype distribution of human papillomavirus (HPV) in an at-risk and suspected population in Iran.
    BMC Infect Dis. 2026;26:1304.
    PubMed         Abstract available
    
    

    
    BMC Med Imaging

15. GOKHAN ACIKGOZ S, Bakir A, Demir Cendek B, Beyaz H, et al
    Pre-treatment MRI-derived fractal dimension as a prognostic marker in cervical cancer treated with definitive radiotherapy with or without concurrent chemotherapy.
    BMC Med Imaging. 2026 Jul 16. doi: 10.1186/s12880-026-02589.
    PubMed         Abstract available
    
    

    
    BMC Public Health

16. YOON JW, Kim G, Lee ES, Lee SY, et al
    Cervical cancer screening and HPV vaccination among assigned female at birth transgender and gender-diverse individuals in South Korea: findings from the KITE cohort.
    BMC Public Health. 2026 Jul 13. doi: 10.1186/s12889-026-28224.
    PubMed         Abstract available
    
    
17. POURETTE D, Cripps A, Hassine A, Opigez E, et al
    Motivation, Capacity and Opportunities for Cervical Cancer Home-based Vaginal Self-sampling in Reunion Island: a Qualitative Study.
    BMC Public Health. 2026 Jul 11. doi: 10.1186/s12889-026-28369.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

18. YBASETA-MEDINA J, Munive-Bendezu R, Flores-Hernandez N, Curotto-Palomino L, et al
    Association between cervical ectropion and high-grade cervical dysplasia in women of reproductive age.
    BMC Womens Health. 2026;26:352.
    PubMed         Abstract available
    
    
19. ABUDUREHEMU S, Wang X, Wang J, Liu T, et al
    Cold-knife conization versus loop electrosurgical excision for cervical adenocarcinoma in situ: a retrospective cohort study.
    BMC Womens Health. 2026;26:348.
    PubMed         Abstract available
    
    
20. KONG WY, St Sauver JL, Jacobson RM, MacLaughlin KL, et al
    Cervical cancer screening preferences by sexual orientation among persons assigned female at birth.
    BMC Womens Health. 2026 Jul 17. doi: 10.1186/s12905-026-04678.
    PubMed         Abstract available
    
    

    
    Br J Health Psychol

21. WHITE CB, McGregor LM
    '...but look how many lives would have been saved if this was available then' Exploring the acceptability of future Human Papillomavirus self-sampling, and the barriers and facilitators of cervical cancer screening for those with intellectual disabili
    Br J Health Psychol. 2026;31:e70092.
    PubMed         Abstract available
    
    

    
    Brachytherapy

22. NAYAK P, Chopra S, Gupta Y, Saahil W, et al
    Response to letter to editor "Radiomics-based machine-learning approach to predict response at brachytherapy using pretreatment magnetic resonance imaging in locally advanced cervical cancer".
    Brachytherapy. 2026 Jul 13:S1538-4721(26)00069.
    PubMed        
    
    

    
    Cancer Manag Res

23. NITTAYABOON K, Leetanaporn K, Kerdkumthong K, Mayakun J, et al
    Cytotoxic Effect of Halimeda macroloba Crude Extract on Cervical Cancer Spheroid Cells via p-mTOR/mTOR, Apoptosis, and Ferroptosis Pathways.
    Cancer Manag Res. 2026;18:611650.
    PubMed         Abstract available
    
    

    
    Cancer Med

24. PEI K, Li D, Xi M, Zhang J, et al
    Nomogram for Preoperative Prediction of Adjuvant Therapy Requirement Following Radical Surgery in Stage IB Cervical Squamous Cell Carcinoma With Tumor Size
    Cancer Med. 2026;15:e72114.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

25. OBANDO-RODRIGUEZ JS, Vieira-Serna S, Peralta J, Rodriguez J, et al
    Para-Aortic Lymph Node Staging and Oncologic Outcomes in Locally Advanced Cervical Cancer: A Narrative Review.
    Cancers (Basel). 2026;18:2058.
    PubMed         Abstract available
    
    
26. ALBZOUR N, Lam SS
    Systematic Evaluation of Vision Transformers for Automated Cervical Cancer Classification: Optimization, Statistical Validation, and Clinical Interpretability.
    Cancers (Basel). 2026;18:2178.
    PubMed         Abstract available
    
    

    
    Cell Commun Signal

27. ARSLAN S, Barbaud A, Bernauer J, Avoscan L, et al
    Small extracellular vesicle-mediated transfer of HPV16 transcripts from Ca Ski cells increases proliferation of HPV-negative recipient cancer cells.
    Cell Commun Signal. 2026;24:404.
    PubMed         Abstract available
    
    

    
    Cell Death Dis

28. PAN S, Wu Q, Liu H, Zhou Y, et al
    ATP7A-mediated copper ion efflux reprogrammes tumour immunity and promotes cisplatin resistance in cervical cancer.
    Cell Death Dis. 2026 Jul 10. doi: 10.1038/s41419-026-09082.
    PubMed         Abstract available
    
    

    
    Clin Oncol (R Coll Radiol)

29. JIA J, Wang L, Wang F
    Patient Selection and Treatment Heterogeneity in Evaluating Radiotherapy for Metastatic Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2026;57:104282.
    PubMed        
    
    
30. JIA J, Wang L, Wang F
    Nodal Tumour Burden as a Prognostic Marker: Interpreting Volume-Based Risk Stratification in Para-Aortic Node-Positive Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2026;57:104283.
    PubMed        
    
    

    
    Comput Biol Chem

31. GANGA VS, Esakkimuthu S, Subramaniam S
    Integrative network pharmacology and genomic analysis of esculin targeting PARP1 in cervical cancer: Insights from ADME profiling, molecular docking, and biomarker discovery.
    Comput Biol Chem. 2026;124.
    PubMed         Abstract available
    
    

    
    Cytotechnology

32. WANG Y, Gui X
    Bavachinin induces oxidative stress-associated apoptosis and modulates NF-kappaB-associated inflammatory gene expression in cervical cancer cells.
    Cytotechnology. 2026;78:159.
    PubMed         Abstract available
    
    

    
    Data Brief

33. JIANG J, Gao Y, Wang M, Zhang R, et al
    Metabolomic data of melittin-intervened murine cervical cancer cells based on liquid chromatography-mass spectrometry.
    Data Brief. 2026;67:113051.
    PubMed         Abstract available
    
    

    
    Discov Nano

34. KIAEE M, Entezari M, Jebali A, Hashemi M, et al
    Bimetallic nano mixtures enable rapid ultrasensitive detection of high risk HPV for early cervical cancer diagnosis.
    Discov Nano. 2026;21:337.
    PubMed         Abstract available
    
    

    
    Discov Oncol

35. LIU Z, Liu W, Liu Z
    Molecular mechanisms and adjuvant therapeutic potential of alpha-mangostin in cervical cancer.
    Discov Oncol. 2026 Jul 17. doi: 10.1007/s12672-026-05534.
    PubMed         Abstract available
    
    

    
    Ecancermedicalscience

36. HOEGL J, Fernandes A, Hidalgo F, Escalona S, et al
    Diagnostic value of routine endoscopic studies in staging locally advanced cervical cancer: a multicenter experience from a low and middle-income country.
    Ecancermedicalscience. 2026;20:2139.
    PubMed         Abstract available
    
    

    
    Front Immunol

37. WEI Q, Qu H, Yu Y, Gao S, et al
    Neoadjuvant chemotherapy and immunotherapy followed by radical radiotherapy for locally advanced cervical cancer: efficacy and safety.
    Front Immunol. 2026;17:1784958.
    PubMed         Abstract available
    
    
38. GUO Y, Liu Y, He Y, Zhang Y, et al
    HPV viral load predicts immune exhaustion and prognosis in cervical neoplasia.
    Front Immunol. 2026;17:1840435.
    PubMed         Abstract available
    
    

    
    Front Oncol

39. JIANG P, Wang X, Cui S, Ren C, et al
    Solution for the hot spots in adaptive radiotherapy planning for cervical cancer: a case report and review of literature.
    Front Oncol. 2026;16:1862463.
    PubMed         Abstract available
    
    
40. BEREZA K, Kukielka A, Trojnarska D, Grabarek BO, et al
    Multidimensional assessment of urinary dysfunction and quality of life after cervical cancer treatment: a multicenter study integrating urodynamics and patient-reported outcomes.
    Front Oncol. 2026;16:1853725.
    PubMed         Abstract available
    
    

    
    Front Public Health

41. OZDAS T, Donmez E, Ortabag T
    Women's experiences and perspectives on a nurse navigation program for cervical cancer screening: a qualitative study.
    Front Public Health. 2026;14:1883702.
    PubMed        
    
    
42. JAMMALAMADUGU SB, Tirelo L, Youssouf N, Umutesi G, et al
    Individual-level HPV vaccination verification in Botswana: lessons learned from implementation of the HOPE II trial.
    Front Public Health. 2026;14:1821335.
    PubMed         Abstract available
    
    
43. ZHOU Y, Zheng X, Shao D, Cheng F, et al
    Facilitators and barriers to cervical cancer screening among women living with HIV: a systematic review of qualitative studies.
    Front Public Health. 2026;14:1809112.
    PubMed         Abstract available
    
    

    
    Funct Integr Genomics

44. CHEN ML, Chu CY, Zhang FX, Zhang LP, et al
    MiR-4327 targets TP53 to promote cervical cancer cell proliferation.
    Funct Integr Genomics. 2026;26:187.
    PubMed         Abstract available
    
    

    
    Glob Epidemiol

45. HASSAN AA, Sudi LA, Mohamed MD, Abdullahi YB, et al
    Persistently high cervical cancer mortality in India: Beyond screening modality alone.
    Glob Epidemiol. 2026;12:100273.
    PubMed        
    
    

    
    Glob Ment Health (Camb)

46. ABOUELELLA DK, Knettel B, Mwobobia J, Posani S, et al
    Examining stigma associated with human papillomavirus (HPV) and cervical cancer screening and treatment in Africa: a scoping review.
    Glob Ment Health (Camb). 2026;13:e138.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

47. NOGUERAS GONZALEZ GM, Amboree TL, Parker S, Bulsara S, et al
    Barriers to cervical cancer screening and experiences using mailed at-home HPV self-collection kits among US and foreign-born Hispanic women in a safety net health system.
    Gynecol Oncol. 2026;211:238-245.
    PubMed         Abstract available
    
    
48. DIXIT R, Chakrawal A, Purwar R, Pandey M, et al
    Comparative performance of HPV self-sampling and conventional screening methods: A systematic review and bivariate meta-analysis.
    Gynecol Oncol. 2026;210:84-94.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol Rep

49. CULCASI C, Moro F, Merenda E, Rizzi A, et al
    Occult sentinel lymph node metastasis detected by intraoperative ex vivo high-frequency ultrasound in clinically early-stage cervical cancer: a case from the prospective RHINOCERUS study.
    Gynecol Oncol Rep. 2026;66:102162.
    PubMed         Abstract available
    
    

    
    Health Sci Rep

50. RAMOS AM, Bolignani CV, Gottems LBD, Costa AM, et al
    Knowledge and Awareness of HPV, the HPV Vaccine, and Cervical Cancer Among Women From a Brazilian Community: A Community-Based Cross-Sectional Study.
    Health Sci Rep. 2026;9:e72818.
    PubMed         Abstract available
    
    

    
    Healthcare (Basel)

51. AGUSTINA HR, Haroen H, Pahria T, Winarno GNA, et al
    Family Voices in Digital Patient Navigation for Cervical Cancer Care in Indonesia.
    Healthcare (Basel). 2026;14:1809.
    PubMed         Abstract available
    
    

    
    Histol Histopathol

52. SERT F, Serin G, Alanyali S, Ozturk M, et al
    HIF-1alpha falls short, ERCC-1 stands out: Predictive insights in locally advanced cervical cancer.
    Histol Histopathol. 2026 Jul 15:25125. doi: 10.14670.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

53. ZHOU H, Zhang H, Pi R, Yang Y, et al
    Head-to-head comparison of the MyGene human papillomavirus-sexually transmitted infection assay versus the Cobas 4800 human papillomavirus test for detecting high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2026;174:824-835.
    PubMed         Abstract available
    
    
54. HONG Q, Smith LW, Proctor L, Gondara L, et al
    Loop electrosurgical excision procedure and perinatal outcomes post-human papillomavirus cervical screening: A longitudinal cohort study.
    Int J Gynaecol Obstet. 2026;174:793-799.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

55. RAMALHO NM, Lima Sales JTO, Carneiro VCG, Batista TP, et al
    Effect of topical vaginal estrogen after radiotherapy for cervical cancer: a randomized, double-blind pilot trial.
    Int J Gynecol Cancer. 2026;36:104831.
    PubMed         Abstract available
    
    
56. DE MELLO GRAZIANO L, Leis LV, Madia RZ, Hilgert MR, et al
    Rethinking adjuvant treatment intensification in early-stage cervical cancer after radical surgery.
    Int J Gynecol Cancer. 2026 Jun 20:104825. doi: 10.1016/j.ijgc.2026.104825.
    PubMed        
    
    

    
    Int J Mol Med

57. TIAN Y, Zhang Y, Wang L, Li Z, et al
    Recent progress and therapeutic strategies in the treatment of cervical neuroendocrine neoplasms (Review).
    Int J Mol Med. 2026;58:259.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

58. SIFUENTES-PADILLA JL, Granados-Lopez AJ, Campos-Lujan AM, Suarez-Castro A, et al
    Naphthoquinone-Amino Acids Regulate Cellular Cancer Associated Processes, p53 and miR-34a-5p Expression in Immortal and Tumorigenic Cervical Cell Lines.
    Int J Mol Sci. 2026;27:5703.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

59. QU A, Zhuo Y, Zhu H, Sun X, et al
    Nimotuzumab Plus Image-Guided Radiation Therapy for Elderly Patients with Locally Advanced Cervical Squamous Cell Carcinoma: Interim Analysis of a Prospective Multicenter Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2026;125:1381-1387.
    PubMed         Abstract available
    
    

    
    Int J STD AIDS

60. NAICKER N, Liebenberg L, Naidoo K, Osman F, et al
    Diagnostic accuracy of the Xpert HPV assay in women starting antiretroviral treatment in South Africa.
    Int J STD AIDS. 2026 Jun 14:9564624261459075. doi: 10.1177/09564624261459075.
    PubMed         Abstract available
    
    

    
    Int J Womens Health

61. RAKHAT A, Aimagambetova G
    Cervical Cancer Screening in Transition: Global Challenges and Local Realities.
    Int J Womens Health. 2026;18:607741.
    PubMed         Abstract available
    
    
62. WANG M, Xiong S, Qiu X, Hu Z, et al
    Development and Validation of a Prognostic Model for Cervical Cancer Based on Chlamydia trachomatis-Associated Transcriptional Signatures.
    Int J Womens Health. 2026;18:611743.
    PubMed         Abstract available
    
    

    
    J Clin Med

63. JEDRZEJCZYK A, Mawlichanow K, Golec-Cera A, Oplawski M, et al
    Robotic Versus Open Radical Hysterectomy in Early-Stage Cervical Cancer: A Comparative Cohort Study.
    J Clin Med. 2026;15:5168.
    PubMed         Abstract available
    
    

    
    J Comput Assist Tomogr

64. GAYATHRI AP, Patel A, Shah L, Chaiprasit T, et al
    Neuroendocrine Malignancies of the Cervix: What Radiologists Need to Know.
    J Comput Assist Tomogr. 2026;50:566-576.
    PubMed         Abstract available
    
    

    
    J Egypt Natl Canc Inst

65. MENON SS, Gupta M, Bhardwaj A, G Chandraguthi S, et al
    A prospective development and evaluation of a 2D convolutional neural network-based auto-segmentation model for cervical cancer radiotherapy.
    J Egypt Natl Canc Inst. 2026;38:46.
    PubMed         Abstract available
    
    

    
    J Family Med Prim Care

66. OOMMEN AM, Thomas V, Muliyil DE, John NO, et al
    Disparities in survival after cervical cancer between tribal and rural women in Tamil Nadu, India: A retrospective cohort study.
    J Family Med Prim Care. 2026;15:1762-1768.
    PubMed         Abstract available
    
    

    
    J Pharm Sci

67. KAMBLE S, Gurunani G, Bodhankar M
    Comment on "Nano-enabled targeted transdermal therapy for pain management in cervical cancer".
    J Pharm Sci. 2026 Jul 16:104421. doi: 10.1016/j.xphs.2026.104421.
    PubMed        
    
    
68. ODEI-MENSAH B, Adeyemi SA, Choonara YE
    Response to the Letter Regarding "Nano-enabled Targeted Transdermal Therapy for Pain Management in Cervical Cancer".
    J Pharm Sci. 2026 Jul 16:104422. doi: 10.1016/j.xphs.2026.104422.
    PubMed        
    
    

    
    J Prev Med Hyg

69. DOZIE UW, Favour Chisom N, Nwokorie MA, Dozie KCN, et al
    Factors Affecting Pap Smear Screening Among Women of Reproductive Age in Owerri West LGA, Imo State, South-Eastern Nigeria.
    J Prev Med Hyg. 2026;67:E87-E95.
    PubMed         Abstract available
    
    
70. ABID A, Noor M, Maheshwari P, Saeed MH, et al
    Addressing HPV Vaccine Hesitancy: A Crucial Step Toward Cervical Cancer Prevention in Pakistan.
    J Prev Med Hyg. 2026;67:E7-E8.
    PubMed        
    
    

    
    JAMA Netw Open

71. FAROLFI A, Casadei C, Scarpi E, Paoletti E, et al
    Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer.
    JAMA Netw Open. 2026;9:e2623166.
    PubMed         Abstract available
    
    

    
    JCO Glob Oncol

72. MCARDLE RP, Morgan J, Itsura P, Paneru B, et al
    Triangular Partnership in Oncology: The Kenya-Nepal Oncology Network Project for the Control of Breast and Cervical Cancer in Kenya and Nepal.
    JCO Glob Oncol. 2026;12:e2500762.
    PubMed         Abstract available
    
    

    
    Jpn J Radiol

73. TOMIZAWA K, Sakamoto S, Miyasaka Y, Oike T, et al
    MYC upregulation as candidate predictive biomarker for radioresistance in cervical cancer.
    Jpn J Radiol. 2026 Jul 17. doi: 10.1007/s11604-026-02036.
    PubMed         Abstract available
    
    

    
    Lasers Med Sci

74. MOHAMMADIAN S, Seifi Alan M, Rastad H
    CO(2) laser ablation versus conization for cervical intraepithelial neoplasia grade 2: a prospective cohort study.
    Lasers Med Sci. 2026;41:148.
    PubMed         Abstract available
    
    

    
    Med Chem Res

75. YANG H, Li X, Cai Z, Li Y, et al
    Synthesis and growth inhibitory activity of sinomenine derivatives against cervical cancer SiHa cells through targeting the AKT-CyclinD1-p21/p27 pathway.
    Med Chem Res. 2026 Jun 8. doi: 10.1007/s00044-026-03584.
    PubMed         Abstract available
    
    

    
    Onco Targets Ther

76. 
    LOXL 2 Promotes the Epithelial-Mesenchymal Transition and Malignant Progression of Cervical Cancer [Retraction].
    Onco Targets Ther. 2026;19:636792.
    PubMed         Abstract available
    
    

    
    Oncol Lett

77. CHEN H, Yang X, Qin Y, Xu W, et al
    Efficacy and safety of immune checkpoint inhibitors combined with anti-angiogenic agents for advanced cervical cancer: A systematic review and meta-analysis.
    Oncol Lett. 2026;32:387.
    PubMed         Abstract available
    
    

    
    Oncologist

78. RUBAGUMYA F, Kwizera V, Mutetiwabo I, Habimana S, et al
    Feasibility of Decentralized Cervical Cancer Survivorship Care at District Hospitals in Rwanda: A Multi-Site Pilot Implementation Study.
    Oncologist. 2026 Jul 16:oyag275. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Pathobiology

79. PUNTONEN E, Bazzon S, Bongiovanni M, Granados R, et al
    ThinPrep(R) Whole-Slide Digital Images versus Conventional Microscopy in Negative for Intraepithelial Lesion or Malignancy, Atypical Squamous Cells of Undetermined Significance, and Low-Grade Squamous Intraepithelial Lesion Cervical Lesions: European
    Pathobiology. 2026;93:221-231.
    PubMed         Abstract available
    
    

    
    PLoS One

80. YANG S, Hou Y, Wang X, Kang S, et al
    Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
    PLoS One. 2026;21:e0353864.
    PubMed         Abstract available
    
    
81. ZOUZOULAS D, Sofianou I, Chatzistamatiou K, Theodoulidis V, et al
    Comparison of Moducare versus Wait-and-See approach for histologically proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) (MODUCIN1 TRIAL) - Study protocol.
    PLoS One. 2026;21:e0353119.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

82. MISHRA SK, Yeager M, Nelson CW, Zhu B, et al
    Longitudinal analysis of high-risk HPV infections reveals within-host viral genome changes over time.
    PLoS Pathog. 2026;22:e1014362.
    PubMed         Abstract available
    
    

    
    Probiotics Antimicrob Proteins

83. MUKHERJEE A, Chakraborty D, Khamle AR, Sharma DD, et al
    Deciphering the Anticancer Potential of Bifidobacterium longum MB BBLM15 Derived Postbiotic Metabolites in Cervical Cancer: In Vitro, In Silico, and Synergy Studies.
    Probiotics Antimicrob Proteins. 2026 Jul 11. doi: 10.1007/s12602-026-11120.
    PubMed         Abstract available
    
    

    
    Rep Pract Oncol Radiother

84. NDUKWE MI, Balcarova K, Spacek J, Pohankova D, et al
    Fistula occurrence after definitive chemoradiotherapy in metastatic or persistent cervical cancer: a retrospective cohort study.
    Rep Pract Oncol Radiother. 2026;31:322-329.
    PubMed         Abstract available
    
    
85. THAKUR P, Singh K, Lakhanpal V, Gupta M, et al
    Comparative analysis of LDR and HDR intracavitary brachytherapy in cervical cancer: the critical role of overall treatment time - a decade of experience.
    Rep Pract Oncol Radiother. 2026;31:330-340.
    PubMed         Abstract available
    
    

    
    Reprod Fertil

86. CHENG J, Li M, Li C, Ding J, et al
    Global Trends and Insights in Cervical Cancer Research: A Bibliometric Analysis from 2000 to 2024.
    Reprod Fertil. 2026 Jul 14:RAF-25-0174. doi: 10.1530/RAF-25-0174.
    PubMed         Abstract available
    
    

    
    Reprod Sci

87. YANG F, Zhu M, Qiu J, Chen Y, et al
    PCK2 Promotes Ribosome Biogenesis in Cervical Cancer Cells via Interaction with hnRNPK.
    Reprod Sci. 2026 Jul 13. doi: 10.1007/s43032-026-02143.
    PubMed         Abstract available
    
    

    
    Rev Esp Patol

88. RODRIGUEZ JA, Mejia Vargas NJ, Moreno Acuna JE
    Peritoneal angiosarcoma in a patient with a history of cervical cancer treated with radiotherapy: A case report.
    Rev Esp Patol. 2026;59:100891.
    PubMed         Abstract available
    
    

    
    RMD Open

89. GOULENOK T, Sierra C, Florence AM, Gonthier C, et al
    Prevalence and risk factors for high-risk human papillomavirus infection in patients with immune-mediated inflammatory diseases: a prospective study.
    RMD Open. 2026;12:e006955.
    PubMed         Abstract available
    
    
90. GROS C, Goulenok T, Timsit JF, Sacre K, et al
    Risk of cancer induced by human papillomavirus in patients with immune-mediated inflammatory diseases: a nationwide matched cohort study.
    RMD Open. 2026;12:e006927.
    PubMed         Abstract available
    
    

    
    Sci Rep

91. YAGI A, Ikeda S, Sakakibara A, Ito Y, et al
    Trends in age-standardized incidence rates of cancers of HPV-related cancer sites in Osaka, Japan: 1977-2019.
    Sci Rep. 2026;16:21754.
    PubMed         Abstract available
    
    
92. HU Z, Ma L, Huang S, Wei Y, et al
    Cervi-LLM for real time colposcopy lesion detection and interpretable diagnosis.
    Sci Rep. 2026;16:22207.
    PubMed         Abstract available
    
    

    
    Tissue Cell

93. LIU C, Dong C, Qu L, Jiang X, et al
    Abrine inhibits cervical cancer progression by targeting UGT8.
    Tissue Cell. 2026;104.
    PubMed         Abstract available
    
    

    
    Transl Cancer Res

94. HUANG S, Song Y, Zhao Y, Zhang X, et al
    Ailanthone as a novel AKT1 inhibitor that induces mitochondrial apoptosis and exerts anti-tumor activity in cervical cancer.
    Transl Cancer Res. 2026;15:465.
    PubMed         Abstract available
    
    
95. CHEN G, Jiang Q, Xu J, He T, et al
    A senescence-based machine learning model prognosticates and personalizes therapy in cervical cancer.
    Transl Cancer Res. 2026;15:490.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum